BioMED Egypt Official
Sherif Aboelazm has a work experience primarily in the field of quality control in the pharmaceutical industry. Sherif served as the Quality Control Head at BIOMED for Pharmaceutical Industries from March 2020 to the present. Prior to that, they worked as a QC Supervisor at Pentapharma Egypt from September 2018 to March 2020. Before that, Sherif worked as a QC Analyst at Al-Esraa Pharmaceutical Optima from January 2014 to August 2018.
Sherif Aboelazm received their B.Sc. degree in Science with a specialization in Chemistry and Microbiology from Al-Azhar University, where they studied from 2009 to 2013. Additionally, they completed a Six Sigma program in TQM at Brooklyn School. The start and end years for this program were not provided.
This person is not in any teams
This person is not in any offices
BioMED Egypt Official
BioMED Pharmaceutical Industries was founded in 2014 and specializes in the manufacture of healthcare products. We launched our first product in 2014 and have continued to expand our product line over the years. We now offer more than 100 products across 10 therapeutic lines, all designed to improve the quality of life for patients. In 2015, BioMED received its final license for our manufacturing plant, which allowed us to ramp up production and meet the increasing demand for our products. We now have three manufacturing plants, which enables us to produce a wide range of healthcare products for a variety of different indications. About Us “A better life, BioMED’s pledge” BioMED, a pharmaceutical company based in Egypt, specializes in the production of a wide range of pharmaceutical products, including generic and innovative drugs, as well as medical and healthcare products. BioMed, have a strong presence in the domestic market and established international partnerships and distribution networks in many countries around the world. Our dedication lies in providing high-quality, affordable healthcare solutions and we have a strong focus on research and development. BioMED is a leading player in the global pharmaceutical industries and is well-positioned for continued growth and success in the future. Our MISSION “pledge for a better life”: to make a pledge to healthcare providers, society, patients, families, and individuals to improve healthcare and promote a better quality of life through the development and provision of innovative products and services. Our VISION “Our commitment to quality and professionalism” BioMED pledges to become one of the top 20 pharmaceutical companies in Egypt by the end of 2023. We pledge to focus on penetrating the international market and to meet the challenges of operating as a multinational company in the coming decade. Our belief is that, through consistently maintaining high performance levels we can achieve our vision